Overview

Sepsis Diagnostics Market is poised to value over USD 620 million by 2027 end with a noteworthy CAGR of over 8.8% during the forecast period 2020 to 2027.

The increasing geriatric population across the world, regulated governmental initiatives for creating awareness regarding sepsis are some of the primary reasons for the remarkable proliferation of the sepsis diagnostics market. According to a study conducted by the WHO, the number of patients diagnosed with sepsis were over 30 million in 2018, leading to over 5 million deaths every year. Such a high prevalence of sepsis is predicted to increase the requirement for diagnostic solutions, thus augmenting the market growth.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Sepsis Diagnostics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Sepsis Diagnostics Market:

• Biomérieux
• T2 Biosystems
• Luminex
• Becton,Dickinson,And Company (Bd)
• Roche Diagnostics (A Subsidiary Of F. Hoffmann-La Roche Ltd.)
• Danaher
• Thermo Fisher Scientific
• Bruker
• Abbott
• Immunexpress
• Response Biomedical
• Axis-Shield Diagnostics
• Cytosorbents
• Mitsubishi Chemical Europe
• Ekf Diagnostics  

(Note: The list of the major players will be updated with the latest market scenario and trends)

Sepsis Diagnostics Market Segmentation:

By Technology

• Blood Culture
• Immunoassays
• Molecular Diagnostics
  o PCR
  o Peptide Nucleic Acid-Fluorescent In Situ Hybridization
  o Microarrays
  o Syndromic Panel-Based Testing
• Flow Cytometry
• Microfluidics
• Biomarkers

By Product

• Blood Culture Media
• Assays & Reagents
• Instruments
• Software

By Pathogen

•  Bacterial Sepsis
    o  Gram-positive bacteria
    o  Gram-negative bacteria
•  Fungal Sepsis
•  Other Pathogens

By Method

• Conventional Diagnostics
• Automated Diagnostics

By Test Type

• Laboratory Tests
• Point-of-care Tests

By End User

• Hospitals
• Pathology & Reference Laboratories
• Research Laboratories & Academic Institutes

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Sepsis Diagnostics Market By Technology, By Product, By Pathogen, By Method, By Test Type, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
       1.1 Objectives of the Study 
       1.2 Market Definition 
       1.3 Market Scope 
               1.3.1 Years Considered for the Study
               1.3.2 Market Covered
       1.4 Currency 
       1.5 Limitations 
       1.6 Stakeholders 

 2.  Research Methodology 
       2.1 Research Data 
              2.1.1 Secondary Data
                 2.1.1.1 Key Data from Secondary Sources
              2.1.2 Primary Data
                 2.1.2.1 Key Data from Primary Sources
       2.2 Market Size Estimation 
       2.3 Market Breakdown and Data Triangulation 
       2.4 Assumptions for the Study  

3. Executive Summary
       3.1 Market Outlook
       3.2 Segment Outlook
       3.3 Competitive Insights

4. Global Sepsis Diagnostics Market Variables, Trends & Scope
       4.1. Market Lineage Outlook
       4.2. Penetration and Growth Prospect Mapping
       4.3. Industry Value Chain Analysis
       4.4. Cost Analysis Breakdown
       4.5. Technology Overview
       4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances

5. Market Overview
       5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of Sepsis Diagnostics Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                            5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Sepsis Diagnostics Market Analysis Tools 
       6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
       6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
       6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
       6.4. Market Entry Strategies
       6.5. Case Studies

7. Global Sepsis Diagnostics Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million)   7.1. Blood Culture
   7.2. Immunoassays
   7.3. Molecular Diagnostics
        7.3.1. PCR
        7.3.1. Peptide Nucleic Acid-Fluorescent In Situ Hybridization
        7.3.1. Microarrays
  o Syndromic Panel-Based Testing
   7.4. Flow Cytometry
   7.5. Microfluidics
   7.6. Biomarkers

8. Global Sepsis Diagnostics Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million)
       8.1. Blood Culture Media
       8.2. Assays & Reagents
       8.3. Instruments
       8.4. Software 

9. Global Sepsis Diagnostics Market, By Pathogen Historical Analysis and Forecast 2020-2027 (USD Million)
       9.1. Bacterial Sepsis
              9.1.1. Gram-positive bacteria
              9.1.2. Gram-negative bacteria
       9.2. Fungal Sepsis
       9.3. Other Pathogens 

10. Global Sepsis Diagnostics Market, By Method Historical Analysis and Forecast 2020-2027 (USD Million)
       10.1. Conventional Diagnostics
       10.2. Automated Diagnostics 

11. Global Sepsis Diagnostics Market, By Test Type Historical Analysis and Forecast 2020-2027 (USD Million)
       11.1. Laboratory Tests
       11.2. Point-of-care Tests

12. Global Sepsis Diagnostics Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
       12.1. Hospitals
       12.2. Pathology & Reference Laboratories  
       12.3. Research Laboratories & Academic Institutes

13.  North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       13.1. Introduction
       13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            13.2.1. U.S.A
            13.2.2. Canada
            13.2.3. Mexico
       13.3. Market Size (USD Million) Forecast for North America 2020-2027

14. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       14.1. Introduction
       14.2. Regional Market Trends
       14.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            14.3.1. Brazil
            14.3.2. Venezuela
            14.3.3. Argentina
            14.3.4. Rest of Latin America
       14.4. Market Size (USD Million) Forecast for Latin America 2020-2027

15. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       15.1. Introduction
       15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            15.2.1. Germany
            15.2.2. U.K
            15.2.3. France
            15.2.4. Italy
            15.2.5. Spain
            15.2.6. Russia
            15.2.7. Poland
            15.2.8. Switzerland
            15.2.9. Rest of Western Europe

16. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       16.1. Introduction
       16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
             16.2.1. Japan
             16.2.2. China
             16.2.3. Singapore
             16.2.4. India
             16.2.5. Australia and New Zealand
             16.2.6. ASEAN
             16.2.7. South Korea
             16.2.8. Rest of Asia Pacific
       16.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027

17. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       17.1. Introduction
       17.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
             17.2.1. Saudi Arabia
             17.2.2. UAE
             17.2.3. South Africa
             17.2.4. Egypt
       17.3. Market Size (USD Million) Forecast for MEA 2020-2027

18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Technology Portfolio, Financial Layouts)
       18.1. Biomérieux
                18.1.1. Company Overview
                18.1.2. Product Portfolio
                18.1.3. SWOT Analysis
                18.1.4. Financial Overview
                18.1.5. Strategic Overview
       18.2. T2 Biosystems
                18.2.1. Company Overview
                18.2.2. Product Portfolio
                18.2.3. SWOT Analysis
                18.2.4. Financial Overview
                18.2.5. Strategic Overview
       18.3. Luminex
                18.3.1. Company Overview
                18.3.2. Product Portfolio
                18.3.3. SWOT Analysis
                18.3.4. Financial Overview
                18.3.5. Strategic Overview
       18.4. Becton,Dickinson and Company (Bd)
                18.4.1. Company Overview
                18.4.2. Product Portfolio
                18.4.3. SWOT Analysis
                18.4.4. Financial Overview
                18.4.5. Strategic Overview
       18.5. Roche Diagnostics (A Subsidiary Of F. Hoffmann-La Roche Ltd.)
                18.5.1. Company Overview
                18.5.2. Product Portfolio
                18.5.3. SWOT Analysis
                18.5.4. Financial Overview
                18.5.5. Strategic Overview
       18.6. Danaher
                18.6.1. Company Overview
                18.6.2. Product Portfolio
                18.6.3. SWOT Analysis
                18.6.4. Financial Overview
                18.6.5. Strategic Overview
       18.7. Thermo Fisher Scientific
                18.7.1. Company Overview
                18.7.2. Product Portfolio
                18.7.3. SWOT Analysis
                18.7.4. Financial Overview
                18.7.5. Strategic Overview
       18.8. Bruker
                18.8.1. Company Overview
                18.8.2. Product Portfolio
                18.8.3. SWOT Analysis
                18.8.4. Financial Overview
                18.8.5. Strategic Overview
       18.9. Abbott
                18.9.1. Company Overview
                18.9.2. Product Portfolio
                18.9.3. SWOT Analysis
                18.9.4. Financial Overview
                18.9.5. Strategic Overview
       18.10. Immunexpress
                18.10.1. Company Overview
                18.10.2. Product Portfolio
                18.10.3. SWOT Analysis
                18.10.4. Financial Overview
                18.10.5. Strategic Overview
       18.11. Response Biomedical
                18.11.1. Company Overview
                18.11.2. Product Portfolio
                18.11.3. SWOT Analysis
                18.11.4. Financial Overview
                18.11.5. Strategic Overview
       18.12. Axis-Shield Diagnostics
                18.12.1. Company Overview
                18.12.2. Product Portfolio
                18.12.3. SWOT Analysis
                18.12.4. Financial Overview
                18.12.5. Strategic Overview
       18.13. Cytosorbents
                18.13.1. Company Overview
                18.13.2. Product Portfolio
                18.13.3. SWOT Analysis
                18.13.4. Financial Overview
                18.13.5. Strategic Overview
       18.14. Mitsubishi Chemical Europe
                18.14.1. Company Overview
                18.14.2. Product Portfolio
                18.14.3. SWOT Analysis
                18.14.4. Financial Overview
                18.14.5. Strategic Overview
       18.15. Ekf Diagnostics
                18.15.1. Company Overview
                18.15.2. Product Portfolio
                18.15.3. SWOT Analysis
                18.15.4. Financial Overview
                18.15.5. Strategic Overview

19. FutureWise SME key takeaway points for Client

Tables

Figures